JCLGX | JQLGX | JCLGX / JQLGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 13 years | - |
Gain YTD | 2.762 | 2.869 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.56B | 8.56B | 100% |
Annual Yield % from dividends | 0.99 | 1.55 | 64% |
Returns for 1 year | 10.16 | 10.87 | 93% |
Returns for 3 years | -2.75 | -1.42 | 193% |
Returns for 5 years | 5.03 | 7.44 | 68% |
Returns for 10 years | -5.92 | -2.27 | 261% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HHHFX | 17.54 | -0.05 | -0.28% |
Hartford Schroders Emerging Mkts Eq F | |||
PHLQX | 45.40 | -0.24 | -0.53% |
PGIM Jennison Health Sciences R6 | |||
AAISX | 16.85 | -0.11 | -0.65% |
American Beacon International Eq Adv | |||
AMRGX | 7.14 | -0.10 | -1.38% |
American Growth One D | |||
DCFGX | 34.14 | -0.75 | -2.15% |
Dunham Focused Large Cap Growth C |